EHJ Dialogue on Factor XI Inhibition in Atrial Fibrillation

EHJ Dialogue with Prof. Faiez ZannadПодробнее

EHJ Dialogue on SGLT2 in heart failureПодробнее

EHJ Dialogue December 2022Подробнее

EHJ Dialogue with Prof. Gregory Lip on the ABC ApproachПодробнее

EHJ Today - Guidelines on atrial fibrillationПодробнее

EHJ Dialogue with Prof. Gregory Lip on ABC ApproachПодробнее

EHJ Dialogue January 2023Подробнее

Will Factor XI Be the Goldilocks Anticoagulant Target?Подробнее

Effective dialogue with your atrial fibrillation patientsПодробнее

Atrial Fibrillation Refresher - A Recap of the Latest GuidelinesПодробнее

Preventing Stroke in Atrial Fibrillation: Unrealized Opportunities , with Christopher Granger, MDПодробнее

Translation Applications of Atrial Fibrosis in ElectrophysiologyПодробнее

Atrial Fibrillation: John's StoryПодробнее

EHJ Annual Board MeetingПодробнее

Performance of oral anticoagulants in high risk patient populations with atrial fibrillationПодробнее

Management of Atrial Fibrillation (AF) with ACS and/or Undergoing PCIПодробнее

ESC 2015: Anticoagulants in atrial fibrillation: Identifying high risk patientsПодробнее